Table 3. Descriptive Economic Statistics of the Selected Sample According to Patients’ Gender .
| Variables | Female | Male | Total Sample |
| Average number of hospitalizations | 0.529 | 0.357 | 0.422 |
| Average number of chemotherapy cycles | 4.324 | 5.137 | 4.830 |
| Average number of follow-up visits | 10.647 | 13.964 | 12.711 |
| Average number of blood tests | 9.941 | 13.214 | 11.978 |
| Average number of instrumental exams | 8.000 | 6.929 | 7.333 |
| % Of patients involved in a first line trial | 17.65% | 10.71% | 13.33% |
| % Of patients involved in a maintenance line trial | 5.88% | 7.14% | 6.67% |
| % Of patients involved in a second line trial | 11.76% | 25.00% | 20.00% |
| % Of patients involved in a third line trial | 5.88% | 3.57% | 4.44% |
| Average total cost | 7810.14 | 8894.24 | 8484.69 |
| Average hospitalization cost | 6301.10 | 3843.78 | 4826.71 |
| Average chemotherapy cost | 2993.03 | 4843.15 | 4144.22 |
| Average monitoring cost | 2241.02 | 2599.81 | 2464.27 |